FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/03/031950 [Registered on: 12/03/2021] Trial Registered Prospectively
Last Modified On: 11/03/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Yoga & Naturopathy 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Vamandhauti procedure and Shivapalapindi Choorna administration in Gastric disease 
Scientific Title of Study   To Evaluate the efficacy of Vamana dhauti with and without Shivapalapindi in Amlapitta 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Chaudhari Krishnakumari B 
Designation  PG Scholar 
Affiliation  Government Ayurveda Medical College Mysuru 
Address  Room number 12, Department of Swasthavritta, Govt. Ayurveda Medical College and Hospital New Sayyaji Rao Road Mysore - Karnataka

Mysore
KARNATAKA
570001
India 
Phone  9664931100  
Fax    
Email  krishnachaudhari2680@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rekha BV 
Designation  Professor 
Affiliation  Government Ayurveda Medical College Mysuru 
Address  Room Number - 12, Department of Swasthavritta, Govt. Ayurveda Medical College New Sayyaji Rao Road Mysore

Mysore
KARNATAKA
570001
India 
Phone  8073046886  
Fax    
Email  nisargarekha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr CHAUDHARI KRISHNAKUMARI B 
Designation  PG Scholar 
Affiliation  Government Ayurveda Medical College Mysuru 
Address  Room number - 12, Department of Swasthavritta, Govt. Ayurveda Medical College New Sayyaji Rao Road Mysore

Mysore
KARNATAKA
570001
India 
Phone  9664931100  
Fax    
Email  krishnachaudhari2680@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurveda Medical Collage & Hospital, New sayaji rao road, mysuru  
 
Primary Sponsor  
Name  Dr Chaudhari Krishnakumari B 
Address  GOVERNMENT AYURVEDA MEDICAL COLLEGE, MYSURU  
Type of Sponsor  Other [PG Scholar] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Chaudhari Krishnakumari B  Government Ayurveda Medical Collage and Hospital, Mysuru  Room number - 12, Departmnet of Swasthvritta, new sayaji rao road, Mysuru KARNATAKA
Mysore
KARNATAKA 
9664931100

krishnachaudhari2680@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Dr CHAUDHARI KRISHNAKUMARI B  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K929||Disease of digestive system, unspecified. Ayurveda Condition: AMLAPITTAM,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  1- Vaman dhauti 2- SHIVAPALA PINDI   1-giving lukewarm saline water in empty stomach and making the patients vomit. Duration - once only at the beginning of trail Route of administration- Oral 2- Patha, Patola, Yava, Chandana, Dhanyaka, Amalaki, Vasa, Lavanga, Tvak, Gaja pippli , Haritaki, Madhu, Sita and Ghrita Dose - 6gm BD before food Duration - 1 month Route of Administration - Oral 
Intervention  1- Vaman dhauti 2- Shivapalapindi  1- giving lukewarm saline water and making the patient vomit. Dose - Duration - Route of Administration - 2-Shivapalapindi contains dravyas like Patha, Patola, Yava, Chandana, Dhanyaka, Amalaki, Vasa, Lavanga, Tvak, Gaja pippli , Haritaki, Madhu, Sita,Ghrita Dose - 6gm BD before food Duration- 1 month Route of Administration - Oral 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  -Subjects between the age group of 18 to 40 yrs, irrespective of gender, religion, occupation & socio - economic status.
- Subjects having the Classical symptoms of amlapitta as described in Ayurvedic literature will be included.
 
 
ExclusionCriteria 
Details  - Subjects with any other systemic illness like Hypertension, Diabetes mellitus.
- Previously diagnosed cases of ulceration of stomach, esophagus, and duodenum, CA of G.I tract and crohn’s disease.
- Subjects who are not fit for Vaman dhauti will be excluded.
- Pregnant lady & lactating women will be excluded.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduce in the sign and symptoms of Amlapitta  30 days 
 
Secondary Outcome  
Outcome  TimePoints 
other associated symptoms of amlapitta will reduce.  45 days  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/03/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Amlapitta is a primary disorder of annavaha strotas, caused by vitiation of tridoshas which leads to mandagni causing vidagdhajirna which in turns leads to vidahi condition. It is characterized by avipaka, klama, tikta-amlodgara, hrud kanta daha, gaurva, aruchi1.The above symptoms resemble gastric esophageal reflux diseases, which has signs and symptoms of heart burn, regurgitation, nausea, indigestion2.

             The prevalence of GERD in India is likely to be between 8 - 19% 3. Mostly it is seen in 2nd decade of life. Several factors like change in lifestyle in terms of culture, smoking and use of specific food types have contributed to the increased prevalence of GERD in this rapidly progressing society. Though antacids are the most recommended treatment in GERD, it is not permanent treatment to cope up with the current situation. The long term use of antacids can bring side effects including diarrhoea, constipation, changes in metabolism and build up of magnesium. So, there is need of evolving more effective treatment which relives human sufferings.

              Even though there are hundreds of medicinal combination are mentioned in the classics for amlapitta, very few of such medicinal measures are proved by clinical study, hence it is a need of hour to explore the efficacy of remaining ones.

          Vamana dhauti is one among the shadkarma, which is practiced for the removal of kapha pitta dosha4. It acts over amasaya, which is the prime seat of amlapitta. It neutralizes the acid balance in stomach and relives the symptoms.

           Shivapalapindi contains dravyas like Patha, Patola, Yava, Chandana, Dhanyaka,  Amalaki, Vasa, Lavanga, Tvak, Gaja pippli , Haritaki,  Madhu, Sita and Ghrita5, which are kapha-pittahara in nature along with  dipana, pachana, anulomana, grahi properties.

          Hence in this study Vamanadhauti and Shivapalapindi are taken as interventions which may help in reducing the signs & symptoms of amlapitta.

          In this regard the study planned – “To Evaluate the efficacy of Vamana dhauti with and without Shivapalapindi in Amlapitta” is being undertaken.


 
Close